IMVT icon

Immunovant

180 hedge funds and large institutions have $2.24B invested in Immunovant in 2024 Q3 according to their latest regulatory filings, with 19 funds opening new positions, 74 increasing their positions, 63 reducing their positions, and 36 closing their positions.

Holders
180
Holders Change
-17
Holders Change %
-8.63%
% of All Funds
2.6%
Holding in Top 10
7
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+40%
% of All Funds
0.1%
New
19
Increased
74
Reduced
63
Closed
36
Calls
$71.2M
Puts
$21.8M
Net Calls
+$49.4M
Net Calls Change
+$48.7M
Name Market Value Shares Shares
Change
Shares
Change %
AIM
201
Aigen Investment Management
New York
-13,323 Closed
Envestnet Asset Management
202
Envestnet Asset Management
Illinois
-10,799 Closed
SEC
203
Seven Eight Capital
New York
-10,575 Closed
Los Angeles Capital Management
204
Los Angeles Capital Management
California
-10,026 Closed
HCA
205
Harbour Capital Advisors
Virginia
-9,400 Closed
Verition Fund Management
206
Verition Fund Management
Connecticut
-8,944 Closed
LPL Financial
207
LPL Financial
California
-8,848 Closed
CM
208
Castleark Management
Illinois
-5,190 Closed
HT
209
Headlands Technologies
Illinois
-2,927 Closed
Twin Tree Management
210
Twin Tree Management
Texas
-2,201 Closed
CFM
211
Catalyst Funds Management
Australia
-2,200 Closed
Pacer Advisors
212
Pacer Advisors
Pennsylvania
-800 Closed
PTC
213
Private Trust Company
Ohio
-112 Closed
PS
214
Principal Securities
Iowa
-70 Closed
IC
215
Innealta Capital
Texas
-59 Closed
CIBC Private Wealth Group
216
CIBC Private Wealth Group
Georgia
-17 Closed
TCA
217
Troluce Capital Advisors
Puerto Rico
Nomura Asset Management
218
Nomura Asset Management
Japan
CFGS
219
Concourse Financial Group Securities
Alabama
PA
220
Parallel Advisors
California
Nomura Holdings
221
Nomura Holdings
Japan
CSS
222
Cubist Systematic Strategies
Connecticut
BWL
223
Bogart Wealth LLC
Virginia